These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 39267766)
1. The adjuvant BcfA activates antigen presenting cells through TLR4 and supports T Shamseldin MM; Read KA; Hall JM; Tuazon JA; Brown JM; Guo M; Gupta YA; Deora R; Oestreich KJ; Dubey P Front Immunol; 2024; 15():1439418. PubMed ID: 39267766 [TBL] [Abstract][Full Text] [Related]
2. TLR2- and 4-independent immunomodulatory effect of high molecular weight components from Ascaris suum. Favoretto BC; Silva SR; Jacysyn JF; Câmara NO; Faquim-Mauro EL Mol Immunol; 2014 Mar; 58(1):17-26. PubMed ID: 24263181 [TBL] [Abstract][Full Text] [Related]
4. Pertussis toxin-induced cytokine differentiation and clonal expansion of T cells is mediated predominantly via costimulation. Denkinger CM; Denkinger MD; Forsthuber TG Cell Immunol; 2007 Mar; 246(1):46-54. PubMed ID: 17601518 [TBL] [Abstract][Full Text] [Related]
5. Modulation of Th1/Th2 immune responses by killed Propionibacterium acnes and its soluble polysaccharide fraction in a type I hypersensitivity murine model: induction of different activation status of antigen-presenting cells. Squaiella-Baptistão CC; Teixeira D; Mussalem JS; Ishimura ME; Longo-Maugéri IM J Immunol Res; 2015; 2015():132083. PubMed ID: 25973430 [TBL] [Abstract][Full Text] [Related]
6. Pertussis toxin potentiates Th1 and Th2 responses to co-injected antigen: adjuvant action is associated with enhanced regulatory cytokine production and expression of the co-stimulatory molecules B7-1, B7-2 and CD28. Ryan M; McCarthy L; Rappuoli R; Mahon BP; Mills KH Int Immunol; 1998 May; 10(5):651-62. PubMed ID: 9645613 [TBL] [Abstract][Full Text] [Related]
7. The differences in immunoadjuvant mechanisms of TLR3 and TLR4 agonists on the level of antigen-presenting cells during immunization with recombinant adenovirus vector. Lebedeva E; Bagaev A; Pichugin A; Chulkina M; Lysenko A; Tutykhina I; Shmarov M; Logunov D; Naroditsky B; Ataullakhanov R BMC Immunol; 2018 Jul; 19(1):26. PubMed ID: 30055563 [TBL] [Abstract][Full Text] [Related]
8. The Regulatory Roles of Toll-Like Receptor 4 in Secretions of Type 1/Type 2 Relative Cytokines by Splenocytes and Dendritic Cells Exposed to Clonorchis sinensis Excretory/Secretory Products. Hua H; Du Y; Ma R; Zhang BB; Yu Q; Li B; Xu JT; Li XY; Tang RX; Yan C; Zheng KY Inflammation; 2018 Feb; 41(1):213-220. PubMed ID: 29047038 [TBL] [Abstract][Full Text] [Related]
9. Nontoxic Shiga toxin derivatives from Escherichia coli possess adjuvant activity for the augmentation of antigen-specific immune responses via dendritic cell activation. Ohmura M; Yamamoto M; Tomiyama-Miyaji C; Yuki Y; Takeda Y; Kiyono H Infect Immun; 2005 Jul; 73(7):4088-97. PubMed ID: 15972497 [TBL] [Abstract][Full Text] [Related]
10. A novel TLR4 binding protein, 40S ribosomal protein S3, has potential utility as an adjuvant in a dendritic cell-based vaccine. Park HJ; Jang GY; Kim YS; Park JH; Lee SE; Vo MC; Lee JJ; Han HD; Jung ID; Kang TH; Park YM J Immunother Cancer; 2019 Feb; 7(1):60. PubMed ID: 30819254 [TBL] [Abstract][Full Text] [Related]
11. TLR2 and Dectin-1 Signaling in Mouse Hematopoietic Stem and Progenitor Cells Impacts the Ability of the Antigen Presenting Cells They Produce to Activate CD4 T Cells. Martínez A; Bono C; Gozalbo D; Goodridge HS; Gil ML; Yáñez A Cells; 2020 May; 9(5):. PubMed ID: 32466296 [TBL] [Abstract][Full Text] [Related]
12. Enhanced dendritic cell maturation by the B-chain of Korean mistletoe lectin (KML-B), a novel TLR4 agonist. Kim JJ; Hwang YH; Kang KY; Kim I; Kim JB; Park JH; Yoo YC; Yee ST Int Immunopharmacol; 2014 Aug; 21(2):309-19. PubMed ID: 24859056 [TBL] [Abstract][Full Text] [Related]
13. Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice. Goff PH; Hayashi T; He W; Yao S; Cottam HB; Tan GS; Crain B; Krammer F; Messer K; Pu M; Carson DA; Palese P; Corr M J Virol; 2017 Oct; 91(19):. PubMed ID: 28724768 [TBL] [Abstract][Full Text] [Related]
14. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production. Schweitzer AN; Sharpe AH J Immunol; 1998 Sep; 161(6):2762-71. PubMed ID: 9743334 [TBL] [Abstract][Full Text] [Related]
15. Recombinant Ov-ASP-1, a Th1-biased protein adjuvant derived from the helminth Onchocerca volvulus, can directly bind and activate antigen-presenting cells. He Y; Barker SJ; MacDonald AJ; Yu Y; Cao L; Li J; Parhar R; Heck S; Hartmann S; Golenbock DT; Jiang S; Libri NA; Semper AE; Rosenberg WM; Lustigman S J Immunol; 2009 Apr; 182(7):4005-16. PubMed ID: 19299698 [TBL] [Abstract][Full Text] [Related]
16. Silencing SOCS1 via Liposome-Packed siRNA Sustains TLR4-Ligand Adjuvant. Hildebrand D; Metz-Zumaran C; Jaschkowitz G; Heeg K Front Immunol; 2019; 10():1279. PubMed ID: 31214204 [TBL] [Abstract][Full Text] [Related]
17. Pneumococcal DnaJ modulates dendritic cell-mediated Th1 and Th17 immune responses through Toll-like receptor 4 signaling pathway. Wu Y; Cui J; Zhang X; Gao S; Ma F; Yao H; Sun X; He Y; Yin Y; Xu W Immunobiology; 2017 Feb; 222(2):384-393. PubMed ID: 27594384 [TBL] [Abstract][Full Text] [Related]